Insider: Borgeson Blake Director - RECURSION PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 6,259,863 | 0 | 6,259,863 |
| Value | $19,468,173.93 | $0.00 | $19,468,173.93 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/03/2026 | DDS | 170,000 | Direct | COM | $3.46 | $588,200.00 | 6,259,863 |
| 02/03/2026 | DDS | 220,000 | Direct | COM | $4.20 | $924,000.00 | 6,429,863 |
| 01/06/2026 | DDS | 220,000 | Direct | COM | $4.36 | $959,200.00 | 6,649,863 |
| 12/02/2025 | DDS | 220,000 | Direct | COM | $4.37 | $961,400.00 | 6,869,863 |
| 11/12/2024 | DDS | 11,447 | Direct | COM | $7.64 | $87,457.37 | 7,066,113 |
| 10/29/2024 | DDS | 11,447 | Direct | COM | $6.72 | $76,926.13 | 7,077,560 |
| 10/15/2024 | DDS | 11,447 | Direct | COM | $6.67 | $76,326.31 | 7,089,007 |
| 10/01/2024 | DDS | 11,447 | Direct | COM | $6.22 | $71,149.97 | 7,098,428 |
| 09/17/2024 | DDS | 11,447 | Direct | COM | $6.84 | $78,332.97 | 7,109,875 |
| 09/03/2024 | DDS | 11,447 | Direct | COM | $6.27 | $71,717.74 | 7,121,322 |
| 08/20/2024 | DDS | 11,447 | Direct | COM | $7.12 | $81,532.40 | 7,132,769 |
| 08/06/2024 | DDS | 11,447 | Direct | COM | $6.82 | $78,083.42 | 7,144,216 |
| 07/09/2024 | DDS | 11,447 | Direct | COM | $7.32 | $83,734.81 | 7,167,110 |
| 06/25/2024 | DDS | 11,447 | Direct | COM | $9.51 | $108,806.02 | 7,177,116 |
| 06/11/2024 | DDS | 11,447 | Direct | COM | $8.45 | $96,762.64 | 7,188,563 |
| 05/28/2024 | DDS | 11,447 | Direct | COM | $9.17 | $104,942.66 | 7,186,913 |
| 05/14/2024 | DDS | 20,054 | Direct | COM | $10.12 | $202,934.45 | 7,198,360 |
| 04/30/2024 | DDS | 11,447 | Direct | COM | $7.95 | $90,963.59 | 7,218,414 |
| 04/16/2024 | DDS | 11,447 | Direct | COM | $7.66 | $87,725.23 | 7,229,861 |
| 04/02/2024 | DDS | 11,447 | Direct | COM | $8.82 | $100,941.94 | 7,241,308 |
| 03/19/2024 | DDS | 20,054 | Direct | COM | $10.79 | $216,422.77 | 7,252,755 |
| 03/05/2024 | DDS | 20,054 | Direct | COM | $12.06 | $241,805.12 | 7,272,809 |
| 02/20/2024 | DDS | 19,745 | Direct | COM | $12.31 | $243,094.52 | 7,293,172 |
| 02/20/2024 | DDS | 309 | Direct | COM | $13.04 | $4,030.35 | 7,292,863 |
| 02/06/2024 | DDS | 11,447 | Direct | COM | $9.30 | $106,489.15 | 7,312,917 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research